Johnson & Johnson Covid vaccine approved for general use in South Africa
Bloomberg1 April 2021
Subscribe
Johnson & Johnson’s coronavirus vaccine has been approved by South African regulators for general use days after President Cyril Ramaphosa said the country will get more than 30 million doses.
The South African Health Products Regulatory Authority has backed the single-shot candidate with conditions, spokesman Yuven Gounden said by phone on Thursday, without giving further detail.
The US drug maker’s vaccine has so far only been used in the country to inoculate health workers, and its approval is a boost to a national roll out that’s been hit by a series of delays.